ZERBAXA(ceftolozane and tazobactam) combines a novel cephalosporin that has bactericidal action with a proven beta-lactamase inhibitor. Ceftolozane inhibits select penicillin-binding proteins, while tazobactam irreversibly inhibits some beta-lactamases.